Skip to main content

Poliomyelitis Vaccine - Novel Oral (nOPV) Type 2

Product overview

Vaccine type
Polio Vaccine - Novel Oral (nOPV) Type 2
Commercial Name
Poliomyelitis Vaccine - Novel Oral (nOPV) Type 2
Manufacturer
Biological E. Limited
Manufacturer Country
India
Responsible NRA
Central Drugs Standard Control Organization
Country
India
Bulk Suplier
PT Bio Farma (Persero)

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
50
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
Not higher than -20 °C ± 3 °C. The vaccine can also be stored for up to 6 months between +2 °C and +8 °C.
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton box containing 10 vials (500 doses). Dimensions: 11x4.5x4.7 cm
Tertiary Packaging
Carton box containing 720 vials (36000 doses). Dimensions: 66x53x43 cm
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
0.46 cm3/dose (in secondary packaging)